All News

Severity of obstructive sleep apnea in patients was shown to be positively associated with a 3-month depression after ischemic stroke, according to study findings.

President Trump announced yesterday he was taking hydroxychloroquine as a preventive measure for coronavirus disease 2019 (COVID-19) despite reported adverse effects and lack of beneficial evidence; Moderna's COVID-19 vaccine shows early promise; CDC finds less than half of infants 5 months or younger are on track for vital vaccinations.

The approval is the fifth for the immunotherapy in lung cancer and the fourth in non–small cell lung cancer (NSCLC).

Between 2009 and 2018, trends in antibiotic resistance among ocular microorganisms remained mostly unchanged in the United States, according to a study published in JAMA Ophthalmology. However, multidrug resistance, especially among methicillin-resistant staphylococci, remained high throughout the study period.

By 2030, the World Health Organization estimates that 82 million individuals worldwide will be affected by dementia, up from 50 million in 2017 and a 64% increase in prevalence in just 13 years. It is well established that cardiovascular health and cognitive decline are interrelated.

Reduced physical activity and greater nightly variation in sleep duration are associated with less favorable metabolic profiles in adolescents, including higher fat accumulation and higher insulin levels, according to a study published in PLoS One.

The FDA approved Deciphera Pharmaceuticals’ ripretinib (Qinlock), the first drug for fourth-line treatment of advanced gastrointestinal stromal tumors (GISTs). The medication is only indicated for adults who have previously received treatment with 3 or more kinase inhibitor therapies, including imatinib.

President Donald Trump is considering whether to cut off funding to the World Health Organization; relief for the public amid the coronavirus disease 2019 (COVID-19) pandemic remains stagnant as Republicans and Democrats have yet to agree on a new stimulus bill; no spike in COVID-19 cases has been observed so far in reopened states.

By mid-March, large hospitals in the Northeast experienced a 26% decline in average per-facility revenues based on estimated in-network amounts as compared to the same period in 2019. Nationwide, the decrease in revenue for large hospitals was 16%

Identifying the particular genes at play in multiple sclerosis (MS) could lead to a better understanding of the disease, and possibly better therapies for it. A new paper proposes network representation learning as the best method to identify those genes.

When should a child with asthma be considered for biologic therapy? It's important to get the basics right first, argues the author of a recent paper.

Some oncologists refrain from prescribing checkpoint immunotherapy in patients with Kaposi sarcoma who also have psoriasis or other skin conditions. A new case report says the therapy can be successfully completed while still controlling the skin condition.

It’s rare for a patient to be diagnosed with both acute myeloid leukemia and multiple myeloma at the same time, but a new case study suggests there are options to treat both diseases at the same time in such cases.

Biosimilar developers can assuage some physician—and even patient—concerns through coordinated, evidence-based messaging.

A recent study describes the use of a liquid assay to uncover any links between response to treatment and tumor load score in patients with stage 2 or stage 3 cancer with solid tumors. Circulating tumor DNA is linked with more advanced cancer.

Female survivors of breast cancer total over 3.5 million in the United States alone. Coronary heart disease is a leading cause of death among this patient group, as it is for all women.

The cost of giving birth in the United States can vary by thousands of dollars depending on where the birth takes place. In Arkansas, inpatient birth charges come out to roughly $8300, but that total rises to nearly $20,000 in New York.

The worldwide fatality rate from coronavirus disease 2019 (COVID-19) now exceeds 7%, and more than 3 million cases have been reported. Cardiovascular disease is a well-known factor for increasing the risk of contracting this sometimes deadly virus.

Chronic breathlessness not only affects patients with chronic obstructive pulmonary disease (COPD) but also their caregivers, who are mostly women, according to a recent review.

In light of the coronavirus disease 2019 (COVID-19) pandemic, pharmacies have implemented new strategies to ensure their patients continue to receive care, especially for those who have lost their insurance or have underlying conditions, speakers said this week during the Pharmacy Quality Alliance (PQA) 2020 Annual Meeting.

Platelet function may aid in determining disease severity for patients with psoriasis who are at an increased risk of developing cardiovascular disease (CVD) and increased inflammation, a review notes.

Quality, as opposed to duration, was suggested as the optimal target for prevention and intervention in sleep health among adolescents, with potential efficacy cited in improving psychological functioning, according to study findings.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

President Trump will restructure the Strategic National Stockpile and increase America's production of supplies; the National Institutes of Health (NIH) is testing a new combination therapy for coronavirus disease 2019; FDA officials issue warning on Abbott Laboratories' rapid response test.

Patients who are treated with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia are at a higher risk of a secondary malignancy. A new case study suggest the list of potential secondary malignancies should include lymphoplasmacytic lymphoma.

Maureen is senior vice president, director of Value Transformation for PRECISIONvalue. Maureen has extensive experience as a C-level executive, clinician, academician, innovator, and coach in managed, integrated care. Nationally, she has developed innovative products and strategies for industry executives and access decision makers. Under her leadership, organizations have received recognition from eValue8, NCQA, and the National Academy of Medicine for innovative strategies that have reduced hospital readmissions, improved patient safety, and enhanced patient engagement. Since joining Precision, she has led more than 500 strategic quality and population health initiatives with 35 clients in 17 therapeutic areas. Her expertise includes adherence, behavioral health/social wellness, crisis management, patient engagement, population health, quality, social determinants of health, and value-based care.

A new study based on interviews with families and patients undergoing chronic transfusion therapy for sickle cell disease finds that the therapy affects the families in ways that extend beyond health.

This week, the top managed care news included testimony on the response to the COVID-19 pandemic; a rare inflammatory disease emerging in children with COVID-19; a novel cell replacement treatment shows promise in Parkinson disease.